© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent

More articles/Ad

More articles/Ad

More articles

  • Primepulse, the German investment fund focused on the technology sector, has postponed its IPO on the Frankfurt Stock Exchange as a result of poor market conditions.
  • Wire and cable manufacturer Polycab India is planning an IPO of new and existing stock, as backer International Finance Corp looks to cash in part of its stake.
  • A stunning rally in Innovent Biologics caught the market’s attention this week, after the shares surged as much as 46% following their debut in Hong Kong on Wednesday. But whether it marks a turning point for the city’s biotechnology listings — which have performed dismally in the secondary market so far — is less clear, writes John Loh.
  • The privatisation of Kazatomprom, the Kazakh producer of natural uranium, moved ahead on Wednesday after bookrunners kicked off a marketing roadshow and set a price range for the listing.
  • Liaoning Chengda Biotechnology filed for a Hong Kong flotation on Tuesday through sponsors CLSA and GF Capital.
  • Clawback columnist Philippe Espinasse says the latest proposals by Hong Kong’s Law Society could spell bad news for international securities lawyers in the city.